Source: ERS Skills Course 2016
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Pijnenburg (Rotterdam, Netherlands). Inflammatory markers. ERS Skills Course 2016

Member's Comments

Teija Dunder - 15.06.2016 11:39
Clear presentation

Related content which might interest you: Inflammatory phenotypes of COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015 Inflammatory markers in COPD patients with and without cachexia Source: Annual Congress 2012 - COPD comorbidities II Year: 2012 Inflammatory markers in relation to cachexia in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 208s Year: 2003 Inflammatory myofibroblastic tumour Source: Eur Respir J 2010; 35: 1422-1423 Year: 2010 Inflammatory molecular endotypes in bronchiectasis Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019 Inflammatory myofibroblastic tumour of the central airways: treatment and molecular analysis Source: ERJ Open Res, 7 (1) 00151-2020; 10.1183/23120541.00151-2020 Year: 2021 Inflammatory bowel diseases and the lung Source: Eur Respir J 2006; 28: Suppl. 50, 55s Year: 2006 Inflammatory mediators in COPD patients with and without alpha-1-antitrypsin deficiency Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 Biomarkers of eosinophilic inflammation Source: Eur Respir Monogr 2022; 95: 37-50 Year: 2022 Inflammatory markers and lipid profile in COPD patients over nine years Source: International Congress 2017 – COPD biomarkers Year: 2017 The importance of inflammatory markers in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma Source: Research Seminar 2007 - Severe Asthma Year: 2007 Phenotyping of the inflammatory sarcoid response Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases Year: 2004 Leptin, inflammatory biomarkers and body composition in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Inflammatory markers of atherogenesis in patients with uncontrolled severe asthma Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Multi-analyte profiling of inflammatory markers in COPD sputum Source: International Congress 2014 – Translational studies in COPD Year: 2014 Inflammation markers: Dependence from severity of AECOPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Targeting TNF-alpha in inflammatory lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005